HNGE holder plans Rule 144 sale of shares

A holder of HNGE Class A shares has filed a Rule 144 notice to sell 257,900 Class A shares through Merrill Lynch on the NYSE, with an aggregate market value of $9,996,204.

Rhea-AI Filing Summary

A holder of HNGE Class A shares has filed a Rule 144 notice to sell 257,900 Class A shares through Merrill Lynch on the NYSE, with an aggregate market value of $9,996,204. The notice states that 37,919,155 Class A shares were outstanding when the filing was prepared.

The shares to be sold were originally acquired on February 4, 2020 in a private placement from the issuer, paid for in cash. The filing also lists recent sales, including Bessemer Venture Partners X LP selling 373,955 Class A shares on November 18, 2025 for $14,976,898, and Bessemer Venture Partners X Institutional LP selling 351,045 Class A shares the same day for $14,059,352.

Insights

Equity capital markets analyst

Venture funds continue staged secondary sales of HNGE Class A shares under Rule 144.

The filing shows a proposed Rule 144 sale of 257,900 HNGE Class A shares with an $9,996,204 aggregate market value, against 37,919,155 Class A shares outstanding. The seller acquired these shares via a private placement on February 4, 2020, paid in cash.

Recent activity includes multiple sales by Bessemer Venture Partners X LP and Bessemer Venture Partners X Institutional LP, such as 373,955 Class A shares sold for $14,976,898 and 351,045 Class A shares sold for $14,059,352 on November 18, 2025. These are secondary sales by existing holders rather than new share issuance.

The actual impact on trading will depend on execution of this planned sale on the NYSE and any further Rule 144 notices. Subsequent company and holder disclosures may provide additional context on remaining positions and future selling intentions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HNGE Rule 144 filing disclose?

The filing discloses a planned secondary sale of HNGE Class A shares. A holder intends to sell 257,900 Class A shares on the NYSE under Rule 144, originally acquired via a 2020 private placement, with an aggregate market value of $9,996,204 at the time of the notice.

How many HNGE Class A shares are planned for sale under this Rule 144 notice?

The notice covers 257,900 HNGE Class A shares. These shares are to be sold through Merrill Lynch on the NYSE, with an aggregate market value of $9,996,204 when the form was prepared, and were originally purchased for cash in a February 2020 private placement.

What were the recent HNGE share sales by Bessemer Venture Partners?

The filing lists several recent Class A sales by Bessemer funds. Examples include Bessemer Venture Partners X LP selling 373,955 shares on November 18, 2025 for $14,976,898 and Bessemer Venture Partners X Institutional LP selling 351,045 shares that same day for $14,059,352.

How many HNGE Class A shares were outstanding when the Rule 144 notice was filed?

The filing reports 37,919,155 Class A shares outstanding. This figure provides a baseline for understanding the relative size of the proposed 257,900-share Rule 144 sale, which represents a portion of the total Class A equity at the time of the notice.

How and when were the HNGE shares in this Rule 144 sale originally acquired?

The 257,900 HNGE Class A shares were acquired on February 4, 2020. They were obtained directly from the issuer in a private placement transaction, with the purchase price paid in cash on the same date, according to the acquisition details in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 04:50 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001768640
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET, 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Bessemer Venture Partners X LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Merrill Lynch One Bryant Park New York NY 10036	257900	9996204	37919155	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	02/04/2020	Private Placement	Issuer			257900	02/04/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bessemer Venture Partners X LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/18/2025	373955	14976898
Bessemer Venture Partners X LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/26/2025	103160	4979533.2
Bessemer Venture Partners X LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/28/2025	23176	1162403.87
Bessemer Venture Partners X LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	12/05/2025	2614	130612.63
Bessemer Venture Partners X Institutional LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/18/2025	351045	14059352
Bessemer Venture Partners X Institutional LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/26/2025	96840	4674466.8
Bessemer Venture Partners X Institutional LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/28/2025	21757	1091233.21
Bessemer Venture Partners X Institutional LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	12/05/2025	2453	122568.02

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Augie Wilkinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)